Our findings revealed a correlation between low MBL2 expression and the activation of various malignant pathways, including the cell cycle [40], DNA replication, miRNAs in cancer, the vascular endothelial growth factor signaling pathway [41], and the cancer stem cell-related pathway [42]. Here, MBL2 is linked to cancer.